Tyra Biosciences, Inc. (TYRA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 138K | 0 | 0 | 0 | 0 | 0 | 0 | 126K | 122K | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -138K | 0 | 0 | 0 | 0 | 0 | 0 | -126K | -122K | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | 100% | 100% | - | - | - | - | - | - | - |
| Operating Expenses | 41.86M | 36.52M | 32.94M | 31.45M | 31.85M | 29.74M | 28.6M | 23.41M | 22.2M | 25.63M | 23.96M | 16.01M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 8.53M | 8.33M | 7.47M | 7.14M | 6.89M | 7.56M | 5.91M | 5.54M | 5.12M | 4.96M | 4.69M | 3.85M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 33.33M | 28.19M | 25.47M | 24.31M | 24.96M | 22.18M | 22.7M | 17.87M | 17.08M | 20.68M | 19.27M | 12.16M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -42M | -36.52M | -32.94M | -31.45M | -31.85M | -29.74M | -28.6M | -23.53M | -22.32M | -25.63M | -23.96M | -16.01M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -31.86% | -22.77% | -15.17% | -33.66% | -42.68% | -16.03% | -19.37% | -46.95% | -55.73% | -70.69% | -75.62% | -3.8% |
| EBITDA | -41.86M | -36.38M | -32.81M | -31.31M | -31.71M | -29.6M | -28.48M | -23.41M | -22.2M | -25.53M | -23.88M | -15.93M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -32.02% | -22.92% | -15.23% | -33.78% | -42.82% | -15.93% | -19.25% | -46.98% | -55.78% | -70.94% | -76.07% | -3.68% |
| D&A (Non-Cash Add-back) | 138K | 132K | 131K | 140K | 143K | 144K | 127K | 126K | 122K | 102K | 83K | 89K |
| EBIT | -42M | -36.52M | -29.87M | -31.45M | -31.85M | -29.74M | -28.6M | -23.53M | -22.32M | -25.63M | -23.96M | -16.01M |
| Net Interest Income | 2.69M | 2.68M | 0 | 3.35M | 3.7M | 4.17M | 4.59M | 4.83M | 4.13M | 2.81M | 2.81M | 2.74M |
| Interest Income | 2.69M | 2.68M | 0 | 3.35M | 3.7M | 4.17M | 4.59M | 4.83M | 4.13M | 2.81M | 2.82M | 2.76M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5K | 21K |
| Other Income/Expense | 2.69M | 2.68M | 3.08M | 3.35M | 3.7M | 4.17M | 4.59M | 4.83M | 4.13M | 2.8M | 2.81M | 2.74M |
| Pretax Income | -39.3M | -33.83M | -29.87M | -28.1M | -28.15M | -25.57M | -24.02M | -18.7M | -18.19M | -22.83M | -21.15M | -13.27M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -39.3M | -33.83M | -29.87M | -28.1M | -28.15M | -25.57M | -24.02M | -18.7M | -18.19M | -22.83M | -21.15M | -13.27M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -39.64% | -32.31% | -24.37% | -50.24% | -54.72% | -12.01% | -13.54% | -40.91% | -53.13% | -77.05% | -69.09% | 12.08% |
| Net Income (Continuing) | -39.3M | -33.83M | -29.87M | -28.1M | -28.15M | -25.57M | -24.02M | -18.7M | -18.19M | -22.83M | -21.15M | -13.27M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.64 | -0.57 | -0.50 | -0.47 | -0.47 | -0.43 | -0.41 | -0.32 | -0.35 | -0.53 | -0.49 | -0.31 |
| EPS Growth % | -36.17% | -32.56% | -21.95% | -46.88% | -34.29% | 18.87% | 16.33% | -3.23% | -25% | -215.22% | -81.48% | 11.43% |
| EPS (Basic) | -0.64 | -0.57 | -0.50 | -0.47 | -0.47 | -0.43 | -0.41 | -0.32 | -0.35 | -0.53 | -0.49 | -0.31 |
| Diluted Shares Outstanding | 61.75M | 59.6M | 59.67M | 59.55M | 59.34M | 58.87M | 58.87M | 58.67M | 52.23M | 42.97M | 42.87M | 42.59M |
| Basic Shares Outstanding | 61.75M | 59.6M | 59.67M | 59.55M | 59.34M | 58.87M | 58.87M | 58.67M | 52.23M | 42.97M | 42.87M | 42.59M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |